218 results match your criteria: "Salzburger Landeskliniken SALK & Paracelsus Medical University Salzburg PMU[Affiliation]"
Int J Mol Sci
December 2022
Department of Transfusion Medicine, Salzburger Landeskliniken (SALK) & Paracelsus Medical University Salzburg (PMU), 5020 Salzburg, Austria.
Human platelet lysate (HPL) is an efficient alternative for animal serum supplements, significantly enhancing stromal cell proliferation. However, the molecular mechanism behind this growth-promoting effect remains elusive. The aim of this study was to investigate the effect of HPL on cell cycle gene expression in different human stromal cells and to identify the main key players that mediate HPL's growth-enhancing effect.
View Article and Find Full Text PDFGenes (Basel)
November 2022
Department of Pediatrics, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.
Heterozygous deletions at 19q12-q13.11 affecting TSHZ3, the teashirt zinc finger homeobox 3, have been associated with intellectual disability and behavioural issues, congenital anomalies of the kidney and urinary tract (CAKUT), and postnatal growth retardation in humans and mice. encodes a transcription factor regulating the development of neurons but is ubiquitously expressed.
View Article and Find Full Text PDFGraefes Arch Clin Exp Ophthalmol
April 2023
Department of Ophthalmology and Optometry, Paracelsus Medical University Salzburg, Salzburger Landeskliniken, Muellner Hauptstrasse 48, 5020, Salzburg, Austria.
Purpose: This study investigates the course of the endothelial cell density over a period of 5 years after XEN45 implantation (XEN45µm, Allergan Plc., USA) with or without combined cataract surgery.
Methods: This is a prospective, cross-sectional, monocentric, non-randomized clinical trial with the intention to treat a population of the University Eye Clinic Glaucoma Service Salzburg.
Antioxidants (Basel)
November 2022
Department of Pediatrics, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.
Extracellular vesicles (EVs) large-scale production is a crucial point for the translation of EVs from discovery to application of EV-based products. In October 2021, the International Society for Extracellular Vesicles (ISEV), along with support by the FET-OPEN projects, "The Extracellular Vesicle Foundry" (evFOUNDRY) and "Extracellular vesicles from a natural source for tailor-made nanomaterials" (VES4US), organized a workshop entitled "massivEVs" to discuss the potential challenges for translation of EV-based products. This report gives an overview of the topics discussed during "massivEVs", the most important points raised, and the points of consensus reached after discussion among academia and industry representatives.
View Article and Find Full Text PDFNeurol Neuroimmunol Neuroinflamm
November 2022
From the Department of Pediatric Neurology (E.M.W.), Olgahospital/Klinikum Stuttgart; Department of Pediatric Neurology (H.S.T., A. Bertolini, K.R.), Witten/Herdecke University, Datteln, Germany; Department of Pediatric I (M. Baumann, C.L.), Pediatric Neurology, Medical University of Innsbruck, Innsbruck, Austria; LMU Klinikum (A. Blaschek), Hauner Children´s Hospital, Munich; Division of Pediatric Neurology (A.M.), Department of Pediatrics, Medical University of Leipzig; Department of General Pediatrics (M.K.), Neonatology and Pediatric Cardiology, University Childrens Hospital, Heinrich-Heine- University Duesseldorf, Germany; Department of Neurology (B.K.), Medical University Vienna, Austria; Department of Neurology (D.P.), Children's Hospital of Eastern Ontario, University of Ottawa, Canada; Department of Neuropediatrics (M.P.), Children's Hospital DRK Siegen, Germany; Clinical Department of Neurology (K.S., M.R.), Medical University of Innsbruck, Austria; Division of Pediatric Neurology (M. Schimmel), Childrens Hospital, Medical University of Augsburg; Department of Neuropediatrics and Social Pediatrics (C.T.), University Hospital for Children and Adolescent Medicine, Ruhr-University Bochum; Division of Neuropediatrics and Social Pediatrics (S.W.), Childrens Hospital, Cologne; Division of Pediatric Neurology (G.W.), Department of Pediatrics, Asklepios Klinik Nord, Heidberg, Germany; Department of Pediatric Neurology (B.A.), Hacettepe University Faculty of Medicine, Ankara, Turkey; Department of Pediatrics (N.B.), University Hospital Zagreb, Medical University Zagreb, Croatia; Department of Pediatric Neurology (C.B.), Kinderkrankenhaus St. Marien gGmbH, Landshut, Germany; Division of Pediatric Pulmonology (M. Breu), Allergology and Endocrinology, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna; Department of Pediatric Neurology (P.B.), Ostschweizer Kinderspital, St. Gallen, Switzerland; Department of Pediatric Neurology (A.D.M.), Centre for Neuromuscular Disorders, Centre for Translational Neuro- and Behavioral Sciences, University Duisburg-Essen; Department of Pediatric Neurology (K.D.), Children's Hospital Kassel; Department of Neuropediatrics and Muscle Disorders (M.E.), Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; Department of Paediatrics and Adolescent Medicine (A.E.), Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria; Department of Pediatric and Adolescent Medicine (M.F.), Medical University Vienna, Austria; Department of Pediatrics (U.G.-S.), LKH Medical University Graz, Austria; Department of Pediatric Neurology (A.H.), University Children's Hospital, University of Zurich; Zentrum für Kinderneurologie AG (T.I.), Zurich, Schwitzerland; Charité Universitätsmedizin Berlin (E.K.), Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Pediatric Neurology, Germany; Department of Pediatrics (J.K.), Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria; Division of Pediatric Neurology (G.K.), Department of Pediatrics, Caritas-Hospital Bad Mergentheim, Germany; Department of Pediatrics and Adolescent Medicine (S.L.), Hospital Dritter Orden, Munich, Germany; Department of Pediatric Neurology (G.L.), Children's Hospital Altona, Hamburg, Germany; Paediatric Neurology and Neurophysiology Unit (M.N., S.S.), Department of Women's and Children's Health, University Hospital of Padova, Italy; Neuroimmunology Group (M.N., S.S.), Paediatric Research Institute "Città della Speranza," Padova, Italy; Department of Neuropediatrics and Muscle Disorders (A.P.), University Medical Center, Faculty of Medicine, University of Freiburg, Germany; Medical University of Vienna (E.R.-F.), Department of Pediatrics; Department of Neuropediatrics (E.R.-F.), St. Anna Children`s Hospital; Department of Social Medicine (D.R.), Donauspital, Vienna, Austria; Department of Pediatrics (M. Salandin), Division of Pediatric Neurology, Hospital Bozen, Italy; Department of Pediatrics (J.-U.S.), Division of Pediatric Neurology, Gemeinschaftskrankenhaus Herdecke, Medical University Witten, Herdecke, Germany; Department of Pediatrics (J. Stoffels), Division of Neuropediatrics, KJF Klinikum Josefinum, Augsburg, Germany; Neurology Department of Children's University Hospital (J. Strautmanis), Riga Stradins University, Riga, Latvia; Center for Pediatric and Teenage Health Care (D.T.), Child Neurology, Sankt Augustin, Germany; Department of Neuropediatrics (V.T.), University Hospital Carl Gustav Carus, Technische Universität Dresden; and Department of Pediatric Neurology (N.U.), Children's Hospital, Medical University Greifswald, Germany.
Background And Objective: The spectrum of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disorder (MOGAD) comprises monophasic diseases such as acute disseminated encephalomyelitis (ADEM), optic neuritis (ON), and transverse myelitis and relapsing courses of these presentations. Persistently high MOG antibodies (MOG immunoglobulin G [IgG]) are found in patients with a relapsing disease course. Prognostic factors to determine the clinical course of children with a first MOGAD are still lacking.
View Article and Find Full Text PDFHum Mol Genet
March 2023
Department of Pediatrics, Section of Clinical Genetics and Metabolism, University of Colorado, Aurora, CO, USA.
Endosc Int Open
August 2022
Department of Surgery, University Clinics Salzburg, Paracelsus Medical University, Salzburg, Austria.
Endoscopic optical diagnosis is crucial to the therapeutic strategy for early gastrointestinal cancer. It accurately (> 85 %) predicts pT category based on microsurface (SP) and vascular patterns (VP). However, interobserver variability is a major problem.
View Article and Find Full Text PDFAm J Hum Genet
September 2022
Department of Neuromuscular Diseases, University College London, Queen Square, Institute of Neurology, London WC1N 3BG, UK. Electronic address:
Orphanet J Rare Dis
July 2022
University Children's Hospital, Salzburger Landeskliniken and Paracelsus Medical University Salzburg, 5020, Salzburg, Austria.
Background: Alterations in the MYH7 gene can cause cardiac and skeletal myopathies. MYH7-related skeletal myopathies are extremely rare, and the vast majority of causal variants in the MYH7 gene are predicted to alter the rod domain of the of ß-cardiac myosin molecule, resulting in distal muscle weakness as the predominant manifestation. Here we describe two unrelated patients harboring an in-frame deletion in the MYH7 gene that is predicted to result in deletion of a single amino acid (p.
View Article and Find Full Text PDFLangenbecks Arch Surg
November 2022
Department of Radio-Oncology, Academic Teaching Hospital, Feldkirch, Austria.
Purpose: Anastomotic leakage (AL) poses the most serious problem following low anterior resection in patients with rectal cancer independent of surgical approach or technique. The aim of this study was to evaluate risk factors for the occurrence of AL and how they affect the oncological long-term outcome of patients who received neoadjuvant therapy.
Methods: A single centre cohort study of 163 consecutive locally advanced rectal cancer patients (cT3, cT4, N +) that received neoadjuvant therapy followed by resection with primary anastomosis between January 1998 and December 2020 were included in this study.
Endoscopy
December 2022
Department of General, Visceral and Thoracic Surgery, Paracelsus Medical University/ Salzburger Landeskliniken (SALK), Salzburg, Austria.
Cancers (Basel)
June 2022
Department of Surgery, Paracelsus Medical University/Salzburger Landeskliniken (SALK), 5020 Salzburg, Austria.
Background: Robotic surgery represents a novel approach for the treatment of colorectal cancers and has been established as an important and effective method over the last years. The aim of this work was to evaluate the effect of a robotic program on oncological findings compared to conventional laparoscopic surgery within the first three years after the introduction.
Methods: All colorectal cancer patients from two centers that either received robotic-assisted or conventional laparoscopic surgery were included in a comparative study.
Endoscopy
November 2022
Department of Surgery, Paracelsus Medical University/Salzburger Landeskliniken (SALK), Salzburg, Austria.
Int J Neonatal Screen
December 2021
Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, CH-8032 Zurich, Switzerland.
There was an error in the original publication [...
View Article and Find Full Text PDFFront Cell Neurosci
January 2022
Institute of Experimental Neuroregeneration, Spinal Cord Injury & Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University, Salzburg, Austria.
Local inflammation plays a pivotal role in the process of secondary damage after spinal cord injury. We recently reported that acute intravenous application of extracellular vesicles (EVs) secreted by human umbilical cord mesenchymal stromal cells dampens the induction of inflammatory processes following traumatic spinal cord injury. However, systemic application of EVs is associated with delayed delivery to the site of injury and the necessity for high doses to reach therapeutic levels locally.
View Article and Find Full Text PDFEBioMedicine
January 2022
Institute of Tendon and Bone Regeneration, Spinal Cord Injury & Tissue Regeneration Center Salzburg, Paracelsus Medical University, Strubergasse 22, Salzburg 5020, Austria; Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Background: Treatment of degenerating tendons still presents a major challenge, since the aetiology of tendinopathies remains poorly understood. Besides mechanical overuse, further known predisposing factors include rheumatoid arthritis, diabetes, obesity or smoking all of which combine with a systemic inflammation.
Methods: To determine whether the systemic inflammation accompanying these conditions contributes to the onset of tendinopathy, we studied the effect of a systemic inflammation induced by an allergic episode on tendon properties.
Urologe A
January 2022
Universitätsklink für Urologie und Andrologie, Paracelsus Medizinische Universität Salzburg, Universitätsklinik für Urologie und Andrologie der PMU, Salzburger Landeskliniken, Müllner Hauptstraße 48, 5020, Salzburg, Österreich.
Transurethral resection of bladder tumors (TURBT) is the standard of care for the diagnostics and primary treatment of bladder tumors. These are removed by fragmentation using loop diathermy. The resection area is coagulated for hemostasis.
View Article and Find Full Text PDFHum Pathol
February 2022
Odense PIPAC Center (OPC) and Odense Pancreas Center (OPAC), Odense University Hospital, Odense, 5000, Denmark; Department of Surgery, HPB and Upper GI Section, Odense University Hospital, Odense, 5000, Denmark.
Pressurized intraperitoneal aerosol chemotherapy (PIPAC)-directed therapy is a new treatment option for peritoneal metastasis (PM). The 4-tiered Peritoneal Regression Grading Score (PRGS) has been proposed for assessment of histological treatment response. We aimed to evaluate the effect of immunohistochemistry (IHC) on interobserver agreement of the PRGS.
View Article and Find Full Text PDFEMBO Mol Med
September 2021
University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.
Congenital disorders of glycosylation are a genetically and phenotypically heterogeneous family of diseases affecting the co- and posttranslational modification of proteins. Using exome sequencing, we detected biallelic variants in GFUS (NM_003313.4) c.
View Article and Find Full Text PDFJ Inherit Metab Dis
November 2021
University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.
Fucosylation is essential for intercellular and intracellular recognition, cell-cell interaction, fertilization, and inflammatory processes. Only five types of congenital disorders of glycosylation (CDG) related to an impaired fucosylation have been described to date: FUT8-CDG, FCSK-CDG, POFUT1-CDG SLC35C1-CDG, and the only recently described GFUS-CDG. This review summarizes the clinical findings of all hitherto known 25 patients affected with those defects with regard to their pathophysiology and genotype.
View Article and Find Full Text PDFInt J Neonatal Screen
June 2021
Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, CH-8032 Zurich, Switzerland.
Glutaric aciduria type I (GA-1) is a rare autosomal-recessive disorder of the degradation of the amino acids lysine and tryptophan caused by mutations of the gene encoding glutaryl-CoA-dehydrogenase. Newborn screening (NBS) for this condition is based on elevated levels of glutarylcarnitine (C5DC) in dried blood spots (DBS). Here we report four cases from three families in whom a correctly performed NBS did not detect the condition.
View Article and Find Full Text PDFJ Extracell Vesicles
June 2021
Extracellular vesicles (EVs) derived from the secretome of human mesenchymal stromal cells (MSC) contain numerous factors that are known to exert anti-inflammatory effects. MSC-EVs may serve as promising cell-based therapeutics for the inner ear to attenuate inflammation-based side effects from cochlear implantation which represents an unmet clinical need. In an individual treatment performed on a 'named patient basis', we intraoperatively applied allogeneic umbilical cord-derived MSC-EVs (UC-MSC-EVs) produced according to good manufacturing practice.
View Article and Find Full Text PDFMol Genet Metab
July 2021
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. Electronic address:
Background: High rates of lost to follow-up (LTFU) adult patients are a major concern in the long-term management of phenylketonuria (PKU). To address this issue, we designed the project "Backtoclinic" with the purpose of identifying LTFU adult PKU patients in Austria as a first step to reestablish appropriate treatment.
Subjects And Methods: Individuals born between 1966 and 1999 and diagnosed with PKU through the National Austrian Newborn Screening Program (NANSP) were identified using the NANSP's database.
Am J Med Genet A
August 2021
Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.